Subscribe To
Opthea to present at the jmp securities life sciences conference
MELBOURNE, Australia, May 08, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing nov...
May 8, 2023, 5:30 am